Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

W. Frenck, Robert; P. Klein, Nicola; Kitchin, Nicholas; Gurtman, Alejandra; Absalon, Judith; Lockhart, Stephen; L. Perez, John; B. Walter, Emmanuel; Senders, Shelly; Bailey, Ruth; A. Swanson, Kena; Ma, Hua; Xu, Xia; Koury, Kenneth; V. Kalina, Warren; Cooper, David; W Jennings, Timothy; M. Brandon, Donald; J. Thomas, Stephen; Türeci, Özlem; B Tresnan, Dina; Mather, Susan; R. Dormitzer, Philip; Şahin, Uğur; U. Jansen, Kathrin; C. Gruber, William

doi:10.1056/nejmoa2107456

Public

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

Published in New England Journal of Medicine • May 27, 2021

Authors:

Robert W. Frenck

Nicola P. Klein

Nicholas Kitchin

Abstract

BACKGROUND: Until very recently, vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had not been authorized for emergency use in persons younger than 16 years of age. Safe, effective vaccines are needed to protect this population, facilitate in-person learning and socializ...

Subject

Reactogenicity

Medicine

Adverse effect

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!